Pharma and Biotech
Research Agreement | 15-Oct-2024 | 07:00 | RNS |
Research and development update | 04-Oct-2024 | 07:00 | RNS |
Directorate Change and grant of options | 26-Sep-2024 | 07:00 | RNS |
Half-year Report | 13-Sep-2024 | 07:00 | RNS |
Commercial Collaboration Progress Update | 28-Aug-2024 | 07:00 | RNS |
Holding(s) in Company | 13-Aug-2024 | 07:00 | RNS |
Directorate Change | 12-Aug-2024 | 10:21 | RNS |
Holding(s) in Company | 08-Aug-2024 | 10:08 | RNS |
Directorate Change | 01-Aug-2024 | 07:00 | RNS |
Total Voting Rights | 31-Jul-2024 | 17:00 | RNS |
Holding(s) in Company | 23-Jul-2024 | 13:59 | RNS |
Commercial Collaboration | 23-Jul-2024 | 07:00 | RNS |
Commercial Collaboration | 18-Jul-2024 | 07:00 | RNS |
Holding(s) in Company | 17-Jul-2024 | 09:28 | RNS |
Directorate Change | 15-Jul-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.20p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.30p |
52 Week Low | 0.12p |
Volume | 0 |
Shares Issued | 2,295.93m |
Market Cap | £4.48m |
Beta | 0.81 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
You are here: research